Description
Retatrutide 20mg is a high-concentration triple-agonist peptide, representing the cutting edge of metabolic research. This 20mg lyophilized vial provides an amplified research tool for investigating the simultaneous activation of the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and GCG (Glucagon) receptors.
Known for its potent synergy, Retatrutide is a primary subject in advanced studies focusing on intensive energy expenditure, glucose homeostasis, and the modulation of hepatic fat.





Reviews
There are no reviews yet.